Helping to Drive Innovative Drugs to Patients Faster

DataCeutics is a specialty Functional Service Provider that drives innovative drugs to patients faster through our strong technical expertise in Biostatistics, Clinical Reporting and Clinical Data Management. By tapping into our team of industry professionals, we can help you tackle the biggest challenge facing the global pharmaceutical industry today- low productivity in development. By providing operational efficiencies and striving to deliver optimal client margins, DataCeutics continues to drive forth quality data and accurate drug reporting to streamline and facilitate development productivity. We can improve outcomes through our highly integrated and strategic partnership model and our consistent focus on and extensive experience with data standards by therapy area.

Support to all Clinical Phases and Therapeutic Areas
At DataCeutics, we devote ourselves to making our clients clinical research assignments perform proficiently and successfully. DataCeutics provides outstanding customer service....more

Rise above with our Biostatistical Quality & Distinction
DataCeutics provides outstanding statistical analyses and programming to all phases of clinical drug development across a wide range of therapeutic areas. Our clients regularly recognize each member of our team of SAS® programmers.… more

 

We Are Experts in Clinical Data Standards
Our experts have eighteen plus years of experience involved with the development and adoption of data standards, including CDASH SDTM and ADaM, since the inception of CDISC over ten years ago. At the heart of our Data Standards Center of.…more

 

Clinical Data Management with Outstanding Excellence
We serve as primary engineers on many clinical studies throughout the industry and have launched systems to support them. Following good clinical data management practices our staff produces solid technical programming products. DataCeutics is ready to help....more
DataCeutics Connects
News and events


Innovative Leader Accelerating the Growth of New Medicines for 20 Years

Since DataCeutics was founded in 1993, the Company has grown to support the evolving needs of the industry. DataCeutics understands the demands to solve common drug development challenges with the end goals of improving clinical studies and bringing new medicines to patients faster. By providing operational efficiencies and striving to deliver optimal client margins, DataCeutics continues to drive forth quality data and accurate drug reporting to streamline and facilitate development productivity. Through highly integrated and strategic partnerships and a pioneer focus on the globalization of data standards by therapy area and disease state, DataCeutics increases the chances of improved client outcomes. 



Looking Forward into 2013 and the Distinctive Therapeutic Value we Offer

DataCeutics is optimistic that R&D in the life science industry will turn a corner in 2013 and that companies will bump up their total spending.  Drug development is becoming more efficient and collaborative in its approach to solving issues, with emerging markets and globalization taking center stage. Data standard ‘harmonization’ is of primary interest to DataCeutics. Our own internal DataCeutics Data Standards Center of Excellence program provides additional value and confirms our commitment to working collaboratively with our clients and CDISC, CFAST, the FDA and the newly formed TransCelerate BioPharma on developing and adopting narrow therapeutic standards relative to specific disease states and conditions. 

 

SCOPE Summit for Clinical Ops Executives, Miami FL --- February 5 - 7, 2013

DataCeutics is pleased to be attending the SCOPE Summit for Clinical Ops Executives in Miami, Florida this February. At this event, we will be discussing the collection and leveraging of electronic data to optimize clinical trials and the implementation and management of strategic alliances, among many other critical topics. This summit will be held at the Hyatt Regency Miami.  

 

FDA/PhUSE Computational Science Symposium, Silver Spring MD --- March 18 - 19, 2013

DataCeutics will be attending the FDA/PhUSE Annual Computational Science Symposium at the Silver Spring Civic Center, Silver Spring, Maryland to discuss updates on data standards and respective industry tools and various process initiatives across regulatory review. We will also be collaborating with key working groups to discuss the improvement of the product lifecycle.

 

8th Global Forum on Clinical Trial Registries, Philadelphia, PA --- April 29 - 30, 2013

DataCeutics is anxious to network and share best practices for managing the ever-growing demands for clinical data registries and results at the Clinical Trials Registries Forum on April 29-30, 2013 at the Radisson Plaza - Warwick Hotel in Philadelphia, PA.  At this year’s conference, there will be a focus on an overview of the global clinical trial disclosure requirements and practical methods to submit information across multiple registries and those strategies to design and implement a successful clinical trial registry.


PharmaSUG Pharmaceutical Industry SAS Users Group, Chicago IL --- May 12 - 15, 2013

DataCeutics will be attending the Pharmaceutical Industry SAS Users Group 2013 Annual Conference at the Chicago Marriott Downtown Magnificent Mile as this is the premier event of the year for SAS users within the pharmaceutical industry. We are excited for this conference as we await the hundreds of high-quality presentations from users, as well as the networking events, demonstrations, and the extensive menu of pre- and post-conference training seminars and exhibits. 

 


ASCO American Society of Clinical Oncology, Chicago IL --- May 31 - June 4, 2013

As the area of oncology is a primary focus for our Company, DataCeutics will be attending the ASCO Annual Meeting- the American Society of Clinical Oncology in May of 2013. This meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring innovative solutions. 

 

 

PhUSE Single Day Event, Cambridge MA --- June 20, 2013

DataCeutics will be attending and sponsoring the PhUSE Single Day Event in Cambridge, Massachusetts on Thursday June 20, 2013. We are pleased to be involved with this single day event. Please check back soon for additional details on this upcoming event.

 


DIA Drug Information Association 2013 49th Annual Meeting, Boston MA --- June 23 - 27, 2013

DataCeutics is anxiously awaiting this year's annual DIA meeting whose theme is Advancing Therapeutic Innovation and Regulatory Science. The event is being held in Boston, Massachusetts at the Boston Convention and Exhibition Center. It is the largest multidisciplinary event that brings together a global network of professionals working on the development of safe and effective medical products and therapies for patients. 

 

International Conference- Proteomics & Bioinformatics, Philadelphia PA --- July 15 - 17, 2013

DataCeutics is interested in attending the 3rd Annual International Conference on Proteomics and Bioinformatics in our home town area of Philadelphia, Pennsylvania. This event will be held at the DoubleTree by Hilton in Center City and will promote the exchange of knowledge and research techniques with experts from pharmaceutical and biotech companies, academicians from leading universities and scientists from research institutions. It will also provide an opportunity to participate in a congress with fellow colleagues, delegates, exhibitors and leading scientists in the field of Proteomics and Bioinformatics.

 

PhUSE Single Day Event, Canton, MI --- September 5, 2013

DataCeutics will be attending and sponsoring the PhUSE Single Day Event in Indianapolis, Indiana on Thursday September 5, 2013. We are pleased to be involved with this single day event. Please check back soon for additional details on this upcoming event.

 

 

CDISC International Interchange 2013, Bethesda MD --- November 4 - 7, 2013

Each year DataCeutics looks forward to the CDISC International Interchange and we are delighted to hear that there is a venue change to Bethesda, Maryland for 2013. CDISC standards are critical to support the acquisition, exchange, submission and archive of clinical research data and metadata. DataCeutics is working collaboratively with CDISC and our clients to assist in the development and support of global, platform-independent data standards by therapeutic area and disease state.